+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Age: 18Years +
MALE
ID07244341

Evaluating Safety and Tolerability of Valemetostat with Darolutamide in Metastatic Castration Resistant Prostate Cancer

Led by Daiichi Sankyo · Updated on 2026-10-26

60

Participants Needed

29

Research Sites

95 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety and tolerability of valemetostat combined with darolutamide in adult males with Metastatic Castration Resistant Prostate Cancer mCRPC. This phase 1 trial aims to understand how these treatments work together in participants who have evidence of disease progression and metastatic spread, while continuing androgen deprivation therapy. The study is sponsored by Daiichi Sankyo and focuses on participants who have prior therapy with androgen receptor pathway inhibitors. Participants will receive valemetostat at escalating doses alongside a standard dose of darolutamide. The trial includes a dose escalation part where dosing is carefully increased, followed by a dose expansion part with two or more dose levels of valemetostat combined with darolutamide. Treatment cycles last 28 days, with valemetostat dosing monitored closely during the initial cycle and repeated in subsequent cycles. Participants will undergo assessments from screening through up to approximately 5 years, including monitoring for dose-limiting toxicities, treatment-emergent adverse events, and prostate-specific antigen PSA responses. Additional evaluations include radiographic progression, overall survival, and time to symptomatic skeletal events. Blood samples will be collected to measure plasma concentrations of the study drugs. Safety and efficacy will be closely tracked throughout the study duration.

CONDITIONS

Brief Title

A Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)

Research Team

C

Contact for Trial Information

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here